Differences in Type Characteristics of Peritoneal Membrane Using Peritoneal Equilibrium Test in End Stage Renal Disease Patients Undergoing Peritoneal Dialysis at Hasan Sadikin Hospital, Bandung

DOI: https://doi.org/10.32867/inakidney.v2i3.192
Keywords: Peritoneal Equilibrium Test, Peritoneal Dialysis, End Stage Renal Disease

Abstract

Background: Peritoneal dialysis (PD) clears solutes and removes fluids from the patient's body. PD failure is primarily due to the clearing of solutes and the removal of fluids. Due to overhydration, the high peritoneal equilibrium test (PET) group is at greater risk of technical failure and death than other groups.

Objective: This study aimed to to determine the characteristics of PET in patients with end-stage renal failure undergoing peritoneal dialysis (PD) at Hasan Sadikin Hospital, Bandung.

Methods: This study is a retrospective, descriptive, and cross-sectional investigation.

Results: Of the 34 PD patients, the PET results were as follows: 47.1% for high average, 14.7% for high, 35.3% for low average, and 2.9% for low.  There were no significant differences in most variables analyzed between the PET groups, including age, gender, etiology, comorbid diseases, history of hemodialysis (HD), residual renal function, and laboratory parameters such as hemoglobin, urea, creatinine, and albumin. The current blood glucose and body mass index (BMI) levels in the high PET group showed higher values and significant differences (p = 0.019 and p = 0.043, respectively).

Conclusion: Blood glucose and BMI may be important factors that distinguish patients with high PET from other PET groups.

Downloads

Download data is not yet available.

References

1. Teitelbaum I. Ultrafiltration failure in peritoneal dialysis: a pathophysiologic approach. Blood Purif. 2015;39(1–3):70–3. doi:10.1159/000368972
2. Intarawongchot P. Factors Associated with High Peritoneal Transport in End-Stage Kidney Disease on Peritoneal Dialysis. J Heal Sci Thail. 2022;31(Supplement 1):146– 154.
3. Dewi M, Bachtiar A. Peritonitis Rate dan Angka Kematian pada Pasein CAPD di Asia Tenggara: Protokol Systematic Review. J Med Hutama [Internet]. 2022;3(2):2135–42. Available from: http://jurnalmedikahutama.com
4. Hansson JH, Watnick S. Update on Peritoneal Dialysis: Core Curriculum 2016. Am J Kidney Dis. 2016;67(1):151–64. doi:10.1053/j.ajkd.2015.06.031
5. Yeekian C, Booncharoeni P. Analysis of Peritoneal Equilibration Test and Risk Factors of High Transporter in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis. TRC Nurse J. 2022;15(1):144–60.
6. Morelle J, Stachowska-Pietka J, Öberg C, Gadola L, Milia V, Yu Z, et al. ISPD recommendations for the evaluation of peritoneal membrane dysfunction in adults: classification, measurement, interpretation and rationale for intervention. Perit Dial Int. 2021;41(4):352–72. doi:10.1177/0896860820982218
7. Daugirdas JT, Blake PG, Ing TS. Handbook of Dialysis. 5th ed. LWW; 2015. 1–844 p.
8. Willis K, Cheung M, Slifer S. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int [Internet]. 2013 Apr 1;3(1):1–163. Available from: https://doi.org/10.1016/j.kint.2023.10.018doi:10.1016/j.kint.2023.10.018
9. Prakash J, Singh LS, Shreeniwas S, Ghosh B, Singh T. Non-infectious complications of continuous ambulatory peritoneal dialysis and their impact on technique survival. Indian J Nephrol. 2011;21(2):112–5. doi:10.4103/0971-4065.82125
10. Chaudhary K. Peritoneal Dialysis Drop-out: Causes and Prevention Strategies. Int J Nephrol. 2011;2011:434608. doi:10.4061/2011/434608
11. Lamb JE, Worral J, Buhler R, Harwood S, Cayi’ell WR, Dawnay AB. Effect of diabetes and peritonitis on the peritoneal equilibration test. Kidney Int. 1995;47(6):1760–1767. doi:10.1038/ki.1995.243
Published
2025-12-24
How to Cite
1.
Budiman M, Afiatin A, Andhika R. Differences in Type Characteristics of Peritoneal Membrane Using Peritoneal Equilibrium Test in End Stage Renal Disease Patients Undergoing Peritoneal Dialysis at Hasan Sadikin Hospital, Bandung. inakidney [Internet]. 24Dec.2025 [cited 5Mar.2026];2(3):101-7. Available from: https://inakidneyhypertension.co.id/index.php/inakidney/article/view/192
Issue
Vol 2 No 3 (2025): Volume 2 No. 3, December 2025
Section
Original Articles

Copyright (c) 2025 Indonesian Journal of Kidney and Hypertension

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with Indonesian Journal of Kidney and Hypertension agree to the following terms:

  1. Authors retain copyright and grant Indonesian Journal of Kidney and Hypertension right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Indonesian Journal of Kidney and Hypertension.
  2. Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Indonesian Journal of Kidney and Hypertension.